Heparin-induced thrombocytopenia primary prevention
|
Heparin-induced thrombocytopenia |
|
Differentiating Heparin-induced thrombocytopenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Heparin-induced thrombocytopenia primary prevention On the Web |
|
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia primary prevention |
|
Heparin-induced thrombocytopenia primary prevention in the news |
|
Blogs on Heparin-induced thrombocytopenia primary prevention |
|
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
|
Risk calculators and risk factors for Heparin-induced thrombocytopenia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]
Overview
Primary prevention for HIT focuses on avoidance of heparin or heparin products. If there is no exposure to heparin, HIT cannot develop. For patients who much receive heparin, the use of low molecular weight heparin is preferred over unfractionated heparin with regards to prevention of HIT.
Primary Prevention
Primary prevention for HIT focuses on avoidance of heparin or heparin products. If there is no exposure to heparin, HIT cannot develop. For patients who much receive heparin, the use of low molecular weight heparin is preferred over unfractionated heparin with regards to prevention of HIT.[1] Avoidance of orthopedic or cardiac surgeries can be primary preventive measures also. Other risk factors for HIT are non-modifiable and thus there are no other primary prevention strategies for HIT.
Reference
- ↑ Arepally GM, Ortel TL (2010). "Heparin-induced thrombocytopenia". Annu Rev Med. 61: 77–90. doi:10.1146/annurev.med.042808.171814. PMC 4153429. PMID 20059332.